GAVI raises $567 million of $2 billion goal to buy COVID-19 vaccines for poor
LONDON (Reuters) - The GAVI vaccines alliance said on Thursday it had raised $567 million towards an initial goal of $2 billion (1.6 billion pounds) from international donors for an Advanced Market Commitment to buy future COVID-19 vaccines for poor countries.
The deal would help secure enough COVID-19 vaccine doses - when the shots have been developed - for poor countries to immunise healthcare workers and those at high risk, it said, as well as creating a "buffer of doses" for use when needed.
(Story corrects to make clear a portion of the target has been raised, not full amount)
(Reporting by Kate Kelland; Editing by Alex Richardson)
